Sign inJoin waitlistJoin the waitlist

SR

Subhransu Ray

MD, Ph.D. · John Muir Health

Credentials: · · · ·

History

John Muir Health
Present

Massachusetts Eye and Ear Infirmary
2000–2001
Ophthalmology
Massachusetts Eye and Ear Infirmary
1997–2000
Preliminary or Transitional Year
1996–1997
Albert Einstein College of Medicine
1992–1996

Research

Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease
Proceedings of the National Academy of Sciences of the United States of America · 1996 · First of 3 authors · 174 citations
Management of vitreoretinal complications in eyes with permanent keratoprosthesis
Archives of Ophthalmology · 2002 · First of 4 authors · 73 citations
Pseudophakic cystoid macular edema
Review · Seminars in Ophthalmology · 2002 · First of 2 authors · Corresponding · 63 citations

Betty Diamond
5 papers
Donald D'Amico
2 papers
JL
John Loewenstein
2 papers
MT
Manoj Thakker
2 papers · 2 as a resident
AE
Alan Epstein
1 paper
AV
Allen Verne
1 paper
AI
Andrey Iliev
1 paper
BK
Bilal Khan
1 paper · 1 as a resident
Chaim Putterman
1 paper
CD
Claes Dohlman
1 paper
CL
Craig Leong
1 paper
Evangelos Gragoudas
1 paper

Clinical trials

A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD
Principal investigator · Completed · Phase 1, Phase 2
Subhransu K. Ray, M.D., Ph.D.
2008–2012
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Principal investigator · Completed · Phase 2
Bay Area Retina Associates
2006–2009
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Site PI · Recruiting · Phase 3
4D Molecular Therapeutics
2025–2029